{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:05:45Z","timestamp":1784084745455,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02313-y","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:55:09Z","timestamp":1779371709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Autoimmune thyroid disease\u2014is high prolactin a risk factor?"],"prefix":"10.1186","volume":"26","author":[{"given":"Seher \u00c7etinkaya","family":"Altunta\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze","family":"Kocaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Erol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"D\u00f6kmeta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"G\u00fcndo\u011fdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asiye","family":"Ar\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande","family":"\u00d6zgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"2313_CR1","doi-asserted-by":"publisher","first-page":"1002320","DOI":"10.3389\/fendo.2022.1002320","volume":"13","author":"P - Kirsch","year":"2022","unstructured":"Kirsch P, Kunadia J, Shah S, Agrawal N. Metabolic effects of prolactin and the role of dopamine agonists: A review. Front Endocrinol (Lausanne). 2022;13:1002320. https:\/\/doi.org\/10.3389\/fendo.2022.1002320.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2313_CR2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.yfrne.2014.02.001","volume":"35","author":"DJ - Lyons","year":"2014","unstructured":"Lyons DJ, Broberger C, TIDAL WAVES. Network mechanisms in the neuroendocrine control of prolactin release. Front Neuroendocrinol. 2014;35(4):420\u201338. https:\/\/doi.org\/10.1016\/j.yfrne.2014.02.001.","journal-title":"Front Neuroendocrinol"},{"key":"2313_CR3","doi-asserted-by":"crossref","unstructured":"Shelly S, Boaz M, Orbach H. Prolactin and autoimmunity. Autoimmun Rev. 2012; May; 11(6\u20137): A465-70.","DOI":"10.1016\/j.autrev.2011.11.009"},{"key":"2313_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3389\/fimmu.2017.00720","volume":"8","author":"MW -Tang","year":"2017","unstructured":"Tang MW, Garcia S, Gerlag DM, Tak PP, Reedquist KA. Insight into the endocrine system and the immune system: a review of the inflammatory role of prolactin in rheumatoid arthritis and psoriatic arthritis. Front Immunol. 2017;8:720.","journal-title":"Front Immunol"},{"issue":"1","key":"2313_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11102-005-5082-5","volume":"8","author":"A -De Bellis","year":"2005","unstructured":"De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A. Prolactin and autoimmunity. Pituitary. 2005;8(1):25\u201330. https:\/\/doi.org\/10.1007\/s11102-005-5082-5.","journal-title":"Pituitary"},{"issue":"1","key":"2313_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12026-016-8817-7","volume":"65","author":"MT -Arango","year":"2017","unstructured":"Arango MT, Perricone C, Kivity S, Cipriano E, Ceccarelli F, Valesini G, et al. HLA-DRB1: the notorious gene in the mosaic of autoimmunity. Immunol Res. 2017;65(1):82\u201398.","journal-title":"Immunol Res"},{"issue":"1","key":"2313_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1590\/0004-2730000002846","volume":"58","author":"ED -Onal","year":"2014","unstructured":"Onal ED, Saglam F, Sacikara M, Ersoy R, Cakir B. Thyroid autoimmunity in patients with hyperprolactinemia: an observational study. Arq Bras Endocrinol Metabol. Feb; 2014;58(1):48\u201352.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"1","key":"2313_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ando.2015.10.008","volume":"77","author":"A -Elenkova","year":"2016","unstructured":"Elenkova A, Petrossians P, Zacharieva S, Beckers A. High prevalence of autoimmune thyroid diseases in patients with prolactinomas: A cross-sectional retrospective study in a single tertiary referral center. Ann Endocrinol. 2016;77(1):37\u201342. https:\/\/doi.org\/10.1016\/j.ando.2015.10.008.","journal-title":"Ann Endocrinol"},{"issue":"3","key":"2313_CR9","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s12020-017-1372-8","volume":"57","author":"A -Elenkova","year":"2017","unstructured":"Elenkova A, \u0410tanasova I, \u041airilov G, Natchev \u0415, Ivanova R, \u041aovatcheva R, Vandeva S, Tcharaktchiev D, Zacharieva S. Autoimmune hypothyroidism is three times more frequent in female prolactinoma patients compared to healthy women: data from a cross-sectional case-control study. Endocrine. 2017;57(3):486\u201393. https:\/\/doi.org\/10.1007\/s12020-017-1372-8.","journal-title":"Endocrine"},{"key":"2313_CR10","doi-asserted-by":"crossref","unstructured":"Sayki Arslan M, Sahin M, Topaloglu O, Tutal E, Karakose M, Gungunes A, Cakal E, Ozbek M, Delibasi T. Hyperprolactinemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma. Clin Endocrinol. 2013 Dec;79(6):882-6","DOI":"10.1111\/cen.12217"},{"key":"2313_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.arcmed.2004.11.007","volume":"36","author":"CK -Kramer","year":"2005","unstructured":"Kramer CK, Tourinho TF, de Castro WP, et al. Association between systemic lupus erythematosus, rheumatoid arthritis, hyperprolactinemia, and thyroid autoantibodies. Arch Med Res. 2005;36:54\u20138.","journal-title":"Arch Med Res"},{"issue":"1","key":"2313_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1530\/acta.0.1040035","volume":"104","author":"C -Ferrari","year":"1983","unstructured":"Ferrari C, Boghen M, Paracchi A, Rampini P, Raiteri F, Benco R, Romussi M, Codecasa F, Mucci M, Bianco M. Thyroid autoimmunity in hyperprolactinaemic disorders. Acta Endocrinol (Copenh). 1983;104(1):35\u201341. https:\/\/doi.org\/10.1530\/acta.0.1040035.","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"3","key":"2313_CR13","first-page":"147","volume":"90","author":"M - Giusti","year":"1999","unstructured":"Giusti M, Foppiani L, Fazzuoli L, Molinari E, Guido R, Valenti S, Giordano G. An increased prevalence of thyroid echographic and autoimmune changes in hyperprolactinemic women on therapy with dopaminergic drugs. Recenti Prog Med. 1999;90(3):147\u201351. Italian.","journal-title":"Recenti Prog Med"},{"key":"2313_CR14","doi-asserted-by":"publisher","first-page":"1015520","DOI":"10.3389\/fendo.2022.1015520","volume":"13","author":"R -Pirchio","year":"2022","unstructured":"Pirchio R, Graziadio C, Colao A, Pivonello R, Auriemma RS. Metabolic effects of prolactin. Front Endocrinol. 2022;13:1015520. https:\/\/doi.org\/10.3389\/fendo.2022.1015520.","journal-title":"Front Endocrinol"},{"key":"2313_CR15","doi-asserted-by":"publisher","first-page":"1001703","DOI":"10.3389\/fendo.2022","volume":"13","author":"Y -Macotela","year":"2022","unstructured":"Macotela Y, Ruiz-Herrera X, V\u00e1zquez-Carrillo DI, Ram\u00edrez-Hernandez G, de la Mart\u00ednez G, Clapp C. The beneficial metabolic actions of prolactin. Front Endocrinol. 2022;13:1001703. https:\/\/doi.org\/10.3389\/fendo.2022.","journal-title":"Front Endocrinol"},{"key":"2313_CR16","doi-asserted-by":"publisher","unstructured":"Laway BA, Sahu D, Bhat MH, Baba MS, Viswanath SA, Misgar RA, Wani AI, Bashir MI, Shah ZA, Mudassar S. Thyroid Autoimmunity and Subclinical Hypothyroidism in Prolactinoma: a case control study. Indian J Endocrinol Metab 2023 Jan-Feb;27(1):45\u20139. https:\/\/doi.org\/10.4103\/ijem.ijem_425_21","DOI":"10.4103\/ijem.ijem_425_21"},{"issue":"11","key":"2313_CR17","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s00296-006-0129-0","volume":"26","author":"Z -Rezaieyazdi","year":"2006","unstructured":"Rezaieyazdi Z, Hesamifard A. Correlation between serum prolactin levels and lupus activity. Rheumatol Int. 2006;26(11):1036\u20139. https:\/\/doi.org\/10.1007\/s00296-006-0129-0.","journal-title":"Rheumatol Int"},{"issue":"1","key":"2313_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/ijms25010110","volume":"25","author":"X Qi-Lytle","year":"2024","unstructured":"Qi-Lytle X, Sayers S, Wagner EJ. Current Review of the Function and Regulation of Tuberoinfundibular Dopamine Neurons. Int J Mol Sci. 2024;25(1):110. https:\/\/doi.org\/10.3390\/ijms25010110.","journal-title":"Int J Mol Sci"},{"key":"2313_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fimmu.2018.00073","volume":"9","author":"VV -Borba","year":"2018","unstructured":"Borba VV, Zandman-Goddard G, Shoenfeld Y. Prolactin Autoimmun Front Immunol. 2018;9:73.","journal-title":"Prolactin Autoimmun Front Immunol"},{"issue":"23","key":"2313_CR20","first-page":"3611","volume":"18","author":"YH -Dong","year":"2014","unstructured":"Dong YH, Fu DG. Autoimmune thyroid disease: mechanism, genetics, and current knowledge. Eur Rev Med Pharmacol Sci. 2014;18(23):3611\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"2313_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1172\/JCI44073","volume":"121","author":"M -Yamamoto","year":"2011","unstructured":"Yamamoto M, Iguchi G, Takeno R, Okimura Y, Sano T, Takahashi M, et al. Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans. J Clin Invest. 2011;121(1):113\u20139.","journal-title":"J Clin Invest"},{"issue":"3","key":"2313_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.autrev.2014.11.005","volume":"14","author":"M - Costanza","year":"2015","unstructured":"Costanza M, Binart N, Steinman L, Pedotti R. Prolactin: a versatile regulator of inflammation and autoimmune pathology. Autoimmun Rev. 2015;14(3):223\u201330. https:\/\/doi.org\/10.1016\/j.autrev.2014.11.005.","journal-title":"Autoimmun Rev"},{"key":"2313_CR23","doi-asserted-by":"publisher","first-page":"1015520","DOI":"10.3389\/fendo.2022.1015520","volume":"13","author":"R - Pirchio","year":"2022","unstructured":"Pirchio R, Graziadio C, Colao A, Pivonello R, Auriemma RS. Metabolic effects of prolactin. Front Endocrinol (Lausanne). 2022;13:1015520. https:\/\/doi.org\/10.3389\/fendo.2022.1015520.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2313_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1590\/0004-2730000002846","volume":"58","author":"ED - Onal","year":"2014","unstructured":"Onal ED, Saglam F, Sacikara M, Ersoy R, Cakir B. Thyroid autoimmunity in patients with hyperprolactinemia: an observational study. Arq Bras Endocrinol Metabol. 2014;58(1):48\u201352. https:\/\/doi.org\/10.1590\/0004-2730000002846.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"11","key":"2313_CR25","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/jcph.1655","volume":"60","author":"R - Krysiak","year":"2020","unstructured":"Krysiak R, Kowalcze K, Okopie\u0144 B. Macroprolactinemia Attenuates the Impact of Levothyroxine on Hypothalamic-Pituitary-Thyroid Axis Activity and Thyroid Autoimmunity in Women With Autoimmune Hypothyroidism. J Clin Pharmacol. 2020;60(11):1496\u2013501. https:\/\/doi.org\/10.1002\/jcph.1655.","journal-title":"J Clin Pharmacol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02313-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02313-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02313-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:45:19Z","timestamp":1784083519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02313-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2313"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02313-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8523918\/v1","asserted-by":"object"}]},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prior to the study, necessary permission was obtained from the Ethics Committee of SB\u00dc Bursa Y\u00fcksek \u0130htisas Training and Research Hospital (Approval No. 2024-TBEK-2025\/03\u201308, Approval Date 12\/03\/2025). Due to the retrospective design of the study, written informed consent was waived. All procedures performed in this study were conducted in accordance with the ethical standards of the institutional and\/or national research committee and the 1964 Helsinki Declaration and its later amendments, or comparable ethical standards.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"207"}}